Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on EquityReturn on SalesTimes Interest Earned

Bioceres Crop Solutions (BIOX) Invested Capital (2016 - 2025)

Bioceres Crop Solutions' Invested Capital history spans 9 years, with the latest figure at $527.8 million for Q2 2025.

  • For Q2 2025, Invested Capital fell 9.25% year-over-year to $527.8 million; the TTM value through Jun 2025 reached $527.8 million, down 9.25%, while the annual FY2025 figure was $527.8 million, 9.25% down from the prior year.
  • Invested Capital for Q2 2025 was $527.8 million at Bioceres Crop Solutions, down from $581.6 million in the prior quarter.
  • Across five years, Invested Capital topped out at $581.6 million in Q2 2024 and bottomed at -$350.1 million in Q4 2021.
  • The 5-year median for Invested Capital is $428.5 million (2022), against an average of $323.9 million.
  • The largest annual shift saw Invested Capital surged 75.86% in 2023 before it fell 9.25% in 2025.
  • A 5-year view of Invested Capital shows it stood at -$350.1 million in 2021, then surged by 194.05% to $329.2 million in 2022, then skyrocketed by 75.86% to $579.0 million in 2023, then increased by 0.45% to $581.6 million in 2024, then fell by 9.25% to $527.8 million in 2025.
  • Per Business Quant, the three most recent readings for BIOX's Invested Capital are $527.8 million (Q2 2025), $581.6 million (Q2 2024), and $579.0 million (Q2 2023).